Generic drug product development : bioequivalence issues / [edited by] Isadore Kanfer, Leon Shargel.
The assessment of bioequivalence is an important process whereby the bioavailability of a generic drug product is compared with its brand-name counterpart. Generic pharmaceutical products must be approved as therapeutic equivalents to the brand name alternative in order to be interchangeable. The de...
Saved in:
| Online Access: |
Full Text (via Taylor & Francis) |
|---|---|
| Other Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
New York :
Informa Healthcare,
©2008.
|
| Series: | Drugs and the pharmaceutical sciences ;
180. |
| Subjects: |
Internet
Full Text (via Taylor & Francis)Online
| Call Number: |
RM301.45 .G42 2008
|
|---|---|
| RM301.45 .G42 2008 | Available |